Patents by Inventor Thomas Anchordoquy

Thomas Anchordoquy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230190653
    Abstract: Described herein are compositions and methods for reducing off-target deposition of therapeutic and/or imaging agents in a subject with cancer comprising administering to the subject a predose of an interferon composition and/or a nucleic acid and a nanoparticle mimic, e.g., a lipoplex composition or a virus-like particle, such that epithelial tightening occurs in nontumor tissue of the subject thereby reducing uptake or accumulation of the therapeutic and/or imaging agent in off-target, nontumor tissue compared to tumor tissue.
    Type: Application
    Filed: December 19, 2022
    Publication date: June 22, 2023
    Inventors: Thomas Anchordoquy, Jamie Betker, Scott Tilden
  • Publication number: 20210369860
    Abstract: Drug delivery systems comprising binding partners conjugated to a nanoparticle encapsulating a therapeutic agent formulated for oral administration, and methods of delivering therapeutic agents across the gastrointestinal epithelium.
    Type: Application
    Filed: October 24, 2019
    Publication date: December 2, 2021
    Inventors: Thomas ANCHORDOQUY, Michael GRANER, Jamie BETKER, Brittany ANGLE
  • Publication number: 20180291086
    Abstract: Lipoplex formulations and uses thereof. In particular, the lipoplexes include at least one naturally-occurring cationic amphiphile, at least one C18-30 saturated fatty acid, cholesterol, at least one nucleic acid, and have a low charge ratio. The lipoplexes are useful for in vivo or in vitro delivery of one or more agents (e.g., a polyanionic therapeutic or an antisense therapeutic, such as an RNAi agent) and allow prolonged expression of these agents, which may be distributed via endogenous cellular pathways to surrounding cells or tissue.
    Type: Application
    Filed: October 5, 2016
    Publication date: October 11, 2018
    Applicant: The Regents of the University of Colorado, a body corporate
    Inventors: Thomas ANCHORDOQUY, Jamie L. BETKER
  • Publication number: 20180280343
    Abstract: Topical compositions containing silibinin with enhanced silibinin penetration into the dermis. The compositions are useful for the treatment or prevention of skin damage or disorders.
    Type: Application
    Filed: October 3, 2016
    Publication date: October 4, 2018
    Inventors: Theresa PACHECO, Thomas ANCHORDOQUY, Rajesh AGARWAL, Neera TEWARI-SINGH
  • Publication number: 20070120280
    Abstract: The methods of the invention employ electrostatic atomization to form a compound droplet of at least two miscible fluids. The compound droplet comprises a core of a first fluid and a layer of a second fluid completely surrounding the core. The first fluid contains the agent to be encapsulated and the second fluid contains an encapsulating agent. The first and second liquids are miscible. The encapsulated droplets can contain a variety of materials including, but not limited to, polynucleotides such as DNA and RNA, proteins, bioactive agents or drugs, food, pesticides, herbicides, fragrances, antifoulants, dyes, oils, inks, cosmetics, catalysts, detergents, curing agents, flavors, fuels, metals, paints, photographic agents, biocides, pigments, plasticizers, propellants and the like and components thereof. The droplets can be encapsulated by a variety of materials, including, but not limited to, lipid bilayers and polymer shells.
    Type: Application
    Filed: May 14, 2004
    Publication date: May 31, 2007
    Applicants: The Regents of the University of Colorato, a body corporate, Colorado Seminary, which owns and operates The University of Denver
    Inventors: Thomas Anchordoquy, Corinne Lengsfeld, Kelly Brinkley, Ryan Jones